Hemodialysis Market Expected to Reach $111.8 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Hemodialysis Market," The hemodialysis market size was valued at $76.9 billion in 2022, and is estimated to reach $111.8 billion by 2032, growing at a CAGR of 3.8% from 2023 to 2032. The function of the kidneys is to remove waste products and excess fluid from the blood. The process is carried out with the help of hemodialysis when the kidneys do not function normally. In hemodialysis, waste products, such as urea and creatinine are removed from the blood with the help of artificial and natural semipermeable membranes. Dialysis machines, dialyzers, catheters, needles, and acidified and bicarbonate concentrates are used in hemodialysis.

Rise in the prevalence of kidney failure boosts the demand for hemodialysis and drives the growth of the hemodialysis market share. For instance, according to the American Kidney Fund, an organization who support people in their fight against kidney disease, in 2022, 37 million Americans had kidney disease and about 807,000 Americans are living with kidney failure. Thus, increase in the number of kidney failure cases propels the growth of the hemodialysis market size.

Furthermore, rise in cases of diabetes and hypertension increases the risk of kidney disease and failure. For instance, according to Centers for Disease Control and Prevention (CDC) 2022, over time, high blood sugar from diabetes can damage blood vessels in the kidneys as well as nephrons so they do not work as well as they should. Also, diabetes also develops high blood pressure, which can damage the kidneys too. Thus, rise in cases of diabetes and hypertension are hemodialysis market trends that drives the growth of the hemodialysis market. 

In addition, rise in R&D activities for the development of novel hemodialysis machine, lack of matching donors, and preference for dialysis over kidney transplant drive the growth of the hemodialysis market. However, risks and complications associated with dialysis and product recall are expected to hamper the market growth.

On the contrary, rise in R&D investments, significant increase in capital income in developed countries, and adoption of developmental strategies such as acquisition, agreement, expansion, merger, partnership, product launch, product approval by key players to stay competitive in the market drive the growth of the hemodialysis market share. For instance, in February 2023, Rockwell Medical, Inc., a commercial healthcare company, announced that it signed a three-year product purchase agreement with Concerto Renal Services, the largest provider of dialysis in skilled nursing facilities in the U.S. Under the terms of the agreement, Rockwell Medical will be the primary supplier of liquid and dry acid and bicarbonate concentrates to Concerto through a three-year commitment that includes supply and purchasing minimums. 

On the basis of product and service, the market is classified into equipment, consumables, drug, and services. The consumables segment is expected to witness the highest CAGR during the forecast period, owing to surge in usage of hemodialysis consumables by hemodialysis patients and rise in demand of hemodialysis consumables in developing countries.

On the basis of type, the hemodialysis market is segregated into conventional hemodialysis, daily hemodialysis, and nocturnal hemodialysis. The nocturnal hemodialysis segment is expected to witness the highest CAGR during the forecast period, owing to its various advantages such as it is done at night, so patients are free in the day to pursue other activities and improves the health of the patient.

On the basis of dialysis site, the hemodialysis market is segregated into in-center dialysis and home dialysis. The home dialysis segment is expected to witness the highest CAGR during the forecast period, owing to its various advantages such as patient can adjust session schedules in the day or at night by letting the treatment fit around the patient timetables and rise in number of people choice for home dialysis options for dialysis treatment.

Region-wise, Asia-Pacific is expected to witness the highest CAGR during the forecast period due to increase in population suffering from kidney failure and surge in healthcare expenditure. In addition, increase in awareness about healthcare and rise in adoption of hemodialysis services are the key trend, which contribute to the expansion of the hemodialysis market in Asia-Pacific. 

Key findings of the study

• On the basis of product and service, the services segment held the largest share in the hemodialysis market analysis in 2022.
• On the basis of type, the conventional hemodialysis segment dominated the hemodialysis industry in 2022.
• On the basis of dialysis site, the in-center dialysis segment dominated the hemodialysis industry in 2022.
• On the basis of region, Asia-Pacific is expected to witness the highest CAGR during the hemodialysis market forecast period.